Health
Oxford/AstraZeneca COVID-19 vaccine strongly efficacious in older adults – The Science Board
Similar safety and immunogenicity profiles were observed in adults and older adults who received the Oxford/AstraZeneca SARS-CoV-2 vaccine candidate, ChAdOx1 nCoV-19,…
A safe and effective vaccine that protects against SARS-CoV-2 infection is an important tool in controlling the global spread of the virus. Given that severe COVID-19 is more common in adults ages 70 years and older, a vaccine that targets this group of individuals in a safe and efficacious manner is desirable. Older adults are affected by immunosenescence, or the gradual decline of immune responses. Therefore, assessment of immune responses with careful regard to this susceptible group is essential…
-
General15 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
Noosa News14 hours agoUnvaccinated horse dies from Hendra virus as Queensland records first case in three years
-
General23 hours agoDe Minaur to face Djokovic at Wimbledon, as Kasatkina bows out in straight sets
-
General17 hours agoBack-to-back rate cuts tipped when Reserve Bank meets